| RS267601099 |
EYS
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS267601384 |
CNTNAP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS267601454 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS267601516 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Maturity-onset diabetes of the young type 2, Permanent neonatal diabetes mellitus 1 |
| RS267601598 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS267601688 |
RP1L1
|
Health Risk |
Conflicting classifications of pathogenicity |
Occult macular dystrophy, Inborn genetic diseases |
| RS267601690 |
RP1L1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 88, Retinitis pigmentosa 88 |
| RS267601810 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, CYP11B1-related disorder |
| RS267601925 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Hereditary spherocytosis type 1 |
| RS267601966 |
CYP7B1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS267602258 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS267602733 |
TECTA
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 21, Autosomal recessive nonsyndromic hearing loss 21 |
| RS267602801 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Transitory neonatal diabetes mellitus, Maturity-onset diabetes of the young |
| RS267602823 |
ANO5
|
Health Risk |
Conflicting classifications of pathogenicity |
Gnathodiaphyseal dysplasia, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS267602849 |
WT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Drash syndrome, Frasier syndrome |
| RS267602852 |
WT1
|
Health Risk |
Likely pathogenic |
Frasier syndrome, Frasier syndrome |
| RS267603200 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS267603422 |
GYS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disorder due to hepatic glycogen synthase deficiency, Glycogen storage disorder due to hepatic glycogen synthase deficiency |
| RS267603424 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS267603451 |
KIF21A
|
Health Risk |
Likely pathogenic |
Congenital fibrosis of extraocular muscles type 1, Congenital fibrosis of extraocular muscles type 1 |
| RS267603461 |
CNTN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Compton-North congenital myopathy, Inborn genetic diseases |
| RS267603591 |
SDR9C7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS267603791 |
ATP8A2
|
Health Risk |
Likely pathogenic |
Cerebellar ataxia, intellectual disability |
| RS267603829 |
TNFSF11
|
Health Risk |
Likely pathogenic |
Autosomal recessive osteopetrosis 2, Autosomal recessive osteopetrosis 2 |
| RS267603840 |
RB1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS267604210 |
UBR1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Johanson-Blizzard syndrome |
| RS267604309 |
BBS4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 4 |
| RS267604368 |
ACAN
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS267604470 |
PALB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS267604575 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Joubert syndrome |
| RS267604688 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS267604735 |
DNAH9
|
Health Risk |
Pathogenic |
— |
| RS267604791 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS267604793 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS267604854 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS267604943 |
COL1A1
|
Health Risk |
Pathogenic |
Infantile cortical hyperostosis, Osteogenesis imperfecta type I |
| RS267604988 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperkalemic periodic paralysis, Potassium-aggravated myotonia |
| RS267605076 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome |
| RS267605077 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS267605146 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 11 |
| RS267605294 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS267605358 |
JAK3
|
Health Risk |
Pathogenic |
T-B+ severe combined immunodeficiency due to JAK3 deficiency, Severe combined immunodeficiency disease |
| RS267605525 |
ETHE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS267605834 |
JAG1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS267606051 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS267606197 |
MYO18B
|
Health Risk |
Pathogenic/Likely pathogenic |
Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome, Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome |
| RS267606230 |
SLC5A1
|
Health Risk |
Likely pathogenic |
Congenital glucose-galactose malabsorption, Congenital glucose-galactose malabsorption |
| RS267606310 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS267606317 |
DCX
|
Health Risk |
Conflicting classifications of pathogenicity |
Ectopic tissue, Lissencephaly type 1 due to doublecortin gene mutation |
| RS267606453 |
RPGR
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 3, Retinitis pigmentosa 3 |
| RS267606510 |
NEXMIF
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked intellectual disability, Cantagrel type |
| RS267606511 |
NEXMIF
|
Health Risk |
Pathogenic |
— |
| RS267606541 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606550 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606552 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606559 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS267606560 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS267606561 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606566 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606567 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS267606568 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS267606569 |
AIP
|
Health Risk |
Likely pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606576 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606578 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606579 |
AIP
|
Health Risk |
Pathogenic/Likely pathogenic |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606580 |
AIP
|
Health Risk |
Pathogenic |
Somatotroph adenoma, Somatotroph adenoma |
| RS267606586 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606589 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Somatotroph adenoma, Hereditary cancer-predisposing syndrome |
| RS267606595 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606596 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606597 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606598 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606599 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606600 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606601 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, familial spinal |
| RS267606602 |
NF1
|
Health Risk |
Pathogenic |
Juvenile myelomonocytic leukemia, Neurofibromatosis |
| RS267606603 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS267606604 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606605 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606606 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis-Noonan syndrome, Café-au-lait macules with pulmonary stenosis |
| RS267606607 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis-Noonan syndrome, Neurofibromatosis |
| RS267606608 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis-Noonan syndrome, Neurofibromatosis-Noonan syndrome |
| RS267606609 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS267606610 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, familial spinal |
| RS267606612 |
MT-CO3
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS267606613 |
MT-CO3
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS267606614 |
MT-CO3
|
Health Risk |
Likely pathogenic |
Mitochondrial complex IV deficiency, nuclear type 1 |
| RS267606621 |
AARS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease |
| RS267606622 |
ABCA12
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 4B, Autosomal recessive congenital ichthyosis 4B |
| RS267606624 |
ABHD12
|
Health Risk |
Pathogenic |
PHARC syndrome, PHARC syndrome |
| RS267606625 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS267606629 |
ACTC1
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 11, Atrial septal defect 5 |
| RS267606630 |
ACTG1
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Autosomal dominant nonsyndromic hearing loss 20 |
| RS267606631 |
ACTG1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 20, Rare genetic deafness |
| RS267606632 |
ACVRL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Telangiectasia, hereditary hemorrhagic |
| RS267606636 |
ADAMTS10
|
Health Risk |
Pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS267606637 |
ADAMTS10
|
Health Risk |
Pathogenic |
Weill-Marchesani syndrome 1, Weill-Marchesani syndrome 1 |
| RS267606638 |
ADAMTS17
|
Health Risk |
Pathogenic |
Weill-Marchesani 4 syndrome, recessive |
| RS267606639 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IIIc, Glycogen storage disease type III |
| RS267606640 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease IIIa, Glycogen storage disease type III |